New players in the programmed cell death mechanism

April 30, 2020

Apoptosis is a form 'cell suicide', in which a series of programmed molecular steps in a cell lead to its death. "When a cell senses that something is wrong, it can commit 'suicide', or apoptosis, to prevent itself from dividing and spreading the problem. This is a normal mechanism present in all cells of the body and one way by which the body gets rid of unneeded or abnormal cells.

"Most cancers block this process, so that they can proliferate forever. So, understanding the process and knowing the actors that are involved is important in order to identify new targets that can be used to develop therapy for cancer, for instance", explains Dominique Leboeuf, Skoltech Center for Life Sciences PhD student and one of the authors of the study.

Apoptosis is an essential process for proper organ development, immune system functioning, and defense against viral infections and cancerous transformation. Once the apoptotic program is initiated in a cell, special enzymes, called caspases, are activated and cleave a very specific set of proteins.

"The goal of the study was to sort out this set and identify the proteins that are important in the apoptotic program. To do this, we looked at the evolutionary conservation of caspase substrates and additional characteristics of these proteins, based on sequence, structure and biochemical properties. We believed that the proteins that were the most preserved, and met our selection criteria, would be critical in the apoptotic process," stated Skoltech Neurobiology and Brain Restoration Center professor Konstantin Piatkov.
-end-
This work is an important step in the understanding of the apoptotic program, and can be used to further investigate the therapeutic potential of the identified proteins.

On this study Skoltech collaborated with Nina Gubina from the RAS Institute of Theoretical and Experimental Biophysics and and Maxim Pyatkov from the RAS Institute of Mathematical Problems of Biology in Pushchino.

Skolkovo Institute of Science and Technology (Skoltech)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.